Re: “Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis” by Kim et al . ( Thyroid 2018;28:1339–1348)
Restricted accessLetterFirst published online June, 2019
Re: “Diagnostic Performance of Technetium-99m Methoxy-Isobutyl-Isonitrile for Differentiation of Malignant Thyroid Nodules: A Systematic Review and Meta-Analysis” by Kim et al . ( Thyroid 2018;28:1339–1348)
KimSJ, LeeSW, JeongSY, PakK, KimK. 2018. Diagnostic performance of technetium-99m methoxy-isobutyl-isonitrile for differentiation of malignant thyroid nodules: a systematic review and meta-analysis. Thyroid, 28:1339–1348.
2.
Hurtado-LópezLM, Arellano-MontañoS, Torres-AcostaEM, Zaldivar-RamirezFR, Duarte-TorresRM, Alonso-De-RuizP, Martínez-DunckerI, Martínez-DunckerC. 2004. Combined use of fine-needle aspiration biopsy, MIBI scans and frozen section biopsy offers the best diagnostic accuracy in the assessment of the hypofunctioning solitary thyroid nodule. Eur J Nucl Med Mol Imaging, 31:1273–1279.
3.
Hurtado-LópezLM, Martínez-DunckerC. 2007. Negative MIBI thyroid scans exclude differentiated and medullary thyroid cancer in 100% of patients with hypofunctioning thyroid nodules. Eur J Nucl Med Mol Imaging, 34:1701–1703.
4.
GiovanellaL, SurianoS, MaffioliM, CerianiL, SprianoG. 2010. (99m)Tc-sestamibi scanning in thyroid nodules with nondiagnostic cytology. Head Neck, 32:607–611.
5.
SaggioratoE, AngustiT, RosasR, MartineseM, FinessiM, AreccoF, TrevisiolE, BergeroN, PulighedduB, VolanteM, PodioV, PapottiM, OrlandiF. 2009. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression. J Nucl Med, 50:1785–1793.
